The hope for self-regulation in industries is naive. If Shell suddenly behaved ethically, its competitors wouldn't. Shell's prices might go up as a consequence; their competitors would win the market share.
Public and legislator pressure must be put on whole industries to agree on minimum ethical standards monitored by an independent watch-body operating at national and international level. Pharmaceutical companies have set up community advisory boards, which may not function ideally, but they are a start in the right direction.
Dr UDO SCHUKLENK
Lecturer in Applied Ethics
University of Central Lancashire